Found: 8
Select item for more details and to access through your institution.
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 108, doi. 10.1111/bjh.19131
- By:
- Publication type:
- Article
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 7, p. 3789, doi. 10.1007/s12325-021-01764-0
- By:
- Publication type:
- Article
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
- Published in:
- 2019
- By:
- Publication type:
- journal article
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 471, doi. 10.1111/bjh.14898
- By:
- Publication type:
- Article
Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 896, doi. 10.1111/bjh.14021
- By:
- Publication type:
- Article
Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 6, p. 886, doi. 10.1111/bjh.13333
- By:
- Publication type:
- Article